Amphastar Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-1.7M | $-24.8M | $23.1M | $6.7M |
| FY2013 | $31.0M | $13.4M | $17.6M | $6.1M |
| FY2014 | $21.1M | $553.0K | $20.5M | $9.3M |
| FY2015 | $10.7M | $-5.3M | $16.0M | $12.8M |
| FY2016 | $38.6M | $17.2M | $21.4M | $15.1M |
| FY2017 | $39.2M | $4.1M | $35.1M | $17.1M |
| FY2018 | $38.2M | $-8.6M | $46.8M | $16.7M |
| FY2019 | $41.8M | $207.0K | $41.6M | $17.3M |
| FY2020 | $57.3M | $23.4M | $33.9M | $20.5M |
| FY2021 | $98.0M | $70.5M | $27.5M | $18.7M |
| FY2022 | $89.2M | $65.1M | $24.0M | $17.9M |
| FY2023 | $183.5M | $145.3M | $38.2M | $20.2M |
| FY2024 | $213.4M | $172.3M | $41.0M | $24.4M |
| FY2025 | $156.1M | $121.2M | $34.9M | $27.3M |